CD4 and adenocarcinoma: It was noted that there was a statistically significant difference for inflammation between the control and study group with the adenocarcinoma subtype and for intratumoral CD4/CD8 ratio between the control and study group with SCC subtype (respectively, p = 0.0008 ve p = 0.0139) (Table 2).